MOLINA ARTURO MD
SEC CIK 1398940 · EDGAR
BoughtSold
Most active insiders at PTGX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | PATEL DINESH V PH D | Pres, CEO, Dir | — | $60.58M |
| 2 | Ali Asif | CFO | — | $7.32M |
| 3 | Giraudo Bryan | Dir | — | $5.92M |
| 4 | Waddill William D. | Dir | — | $5.58M |
| 5 | MOLINA ARTURO MD | Chief Medical Off | — | $4.49M |
| 6 | SELICK HAROLD E | Dir | — | $2.52M |
| 7 | Williams Lewis T | Dir | — | $1.48M |
| 8 | O'Dowd Sarah A | Dir | — | — |
Transactions 27
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-27 | 2026-03-26 | PTGX | Protagonist Therapeutics, Inc | MOLINA ARTURO MD | Chief Medical Off | S - Sale+OE | $104.79 | -15.0K | 84.1K | -15% | -$1.57M |
| D | 2026-03-27 | 2026-03-26 | PTGX | Protagonist Therapeutics, Inc | MOLINA ARTURO MD | Chief Medical Off | M - OptEx | $8.04 | +15.0K | 99.1K | +18% | +$120.6K |
| DM | 2026-01-27 | 2026-01-23+ | PTGX | Protagonist Therapeutics, Inc | MOLINA ARTURO MD | Chief Medical Off | S - Sale+OE | $82.30 | -23.2K | 84.1K | -22% | -$1.91M |
| DM | 2026-01-27 | 2026-01-26+ | PTGX | Protagonist Therapeutics, Inc | MOLINA ARTURO MD | Chief Medical Off | M - OptEx | $8.04 | +10.0K | 89.1K | +13% | +$80.4K |
| 2026-01-21 | 2026-01-20 | PTGX | Protagonist Therapeutics, Inc | MOLINA ARTURO MD | Chief Medical Off | S - Sale | $82.48 | -9,514 | 97.3K | -9% | -$784.7K | |
| D | 2026-01-06 | 2026-01-02 | PTGX | Protagonist Therapeutics, Inc | MOLINA ARTURO MD | Chief Medical Off | A - Grant | $0.00 | +25.6K | 106.8K | +32% | $0 |
| 2025-11-19 | 2025-11-17 | PTGX | Protagonist Therapeutics, Inc | MOLINA ARTURO MD | Chief Medical Off | S - Sale | $84.77 | -2,712 | 81.2K | -3% | -$229.9K | |
| DM | 2025-06-11 | 2025-06-09+ | PTGX | Protagonist Therapeutics, Inc | MOLINA ARTURO MD | Chief Medical Off | S - Sale+OE | $56.27 | -20.0K | 83.9K | -19% | -$1.13M |
| DM | 2025-06-11 | 2025-06-09+ | PTGX | Protagonist Therapeutics, Inc | MOLINA ARTURO MD | Chief Medical Off | M - OptEx | $8.04 | +20.0K | 93.9K | +27% | +$160.8K |
| DM | 2025-03-14 | 2025-03-13 | PTGX | Protagonist Therapeutics, Inc | MOLINA ARTURO MD | Chief Medical Off | M - OptEx | $24.48 | +30.5K | 112.3K | +37% | +$747.0K |
| D | 2025-03-14 | 2025-03-13 | PTGX | Protagonist Therapeutics, Inc | MOLINA ARTURO MD | Chief Medical Off | S - Sale+OE | $55.74 | -30.5K | 83.9K | -27% | -$1.70M |
| M | 2025-01-17 | 2025-01-16 | PTGX | Protagonist Therapeutics, Inc | MOLINA ARTURO MD | Chief Medical Off | S - Sale | $0.00 | -3,640 | 87.1K | -4% | $0 |
| D | 2025-01-06 | 2025-01-02 | PTGX | Protagonist Therapeutics, Inc | MOLINA ARTURO MD | Chief Medical Off | A - Grant | $0.00 | +41.1K | 87.5K | +88% | $0 |
| DM | 2024-11-27 | 2024-11-26+ | PTGX | Protagonist Therapeutics, Inc | MOLINA ARTURO MD | Chief Medical Off | M - OptEx | $8.04 | +31.5K | 52.0K | +154% | +$253.5K |
| DM | 2024-11-27 | 2024-11-26+ | PTGX | Protagonist Therapeutics, Inc | MOLINA ARTURO MD | Chief Medical Off | S - Sale+OE | $44.86 | -31.5K | 46.4K | -40% | -$1.41M |
| 2024-11-19 | 2024-11-15 | PTGX | Protagonist Therapeutics, Inc | MOLINA ARTURO MD | Chief Medical Off | S - Sale | $40.98 | -1,906 | 46.4K | -4% | -$78.1K | |
| 2024-01-18 | 2024-01-16 | PTGX | Protagonist Therapeutics, Inc | MOLINA ARTURO MD | Chief Medical Off | F - Tax | $24.63 | -427 | 48.4K | -0.9% | -$10.5K | |
| D | 2024-01-04 | 2024-01-02 | PTGX | Protagonist Therapeutics, Inc | MOLINA ARTURO MD | Chief Medical Off | A - Grant | $0.00 | +26.2K | 48.8K | +117% | $0 |
| D | 2024-01-04 | 2023-11-15 | PTGX | Protagonist Therapeutics, Inc | MOLINA ARTURO MD | Chief Medical Off | S - Sale | $16.24 | -1,848 | 22.5K | -8% | -$30.0K |
| D | 2023-01-18 | 2023-01-16 | PTGX | Protagonist Therapeutics, Inc | MOLINA ARTURO MD | Chief Medical Off | A - Grant | $0.00 | +3,125 | 24.4K | +15% | $0 |
| D | 2022-11-17 | 2022-11-15 | PTGX | Protagonist Therapeutics, Inc | MOLINA ARTURO MD | Chief Medical Off | A - Grant | $0.00 | +21.2K | 21.2K | New | $0 |
| D | 2022-03-07 | 2022-03-05 | STRO | SUTRO BIOPHARMA, INC. | MOLINA ARTURO MD | Chief Medical Off | F - Tax | $8.17 | -4,355 | 37.7K | -10% | -$35.6K |
| D | 2022-03-07 | 2022-03-05 | STRO | SUTRO BIOPHARMA, INC. | MOLINA ARTURO MD | Chief Medical Off | M - OptEx | — | +12.5K | 42.1K | +42% | — |
| D | 2022-02-01 | 2022-01-29 | STRO | SUTRO BIOPHARMA, INC. | MOLINA ARTURO MD | Chief Medical Off | F - Tax | $10.39 | -2,151 | 29.6K | -7% | -$22.3K |
| D | 2022-02-01 | 2022-01-29 | STRO | SUTRO BIOPHARMA, INC. | MOLINA ARTURO MD | Chief Medical Off | M - OptEx | $0.00 | +5,250 | 31.7K | +20% | $0 |
| D | 2021-09-28 | 2021-09-24 | STRO | SUTRO BIOPHARMA, INC. | MOLINA ARTURO MD | Chief Medical Off | M - OptEx | $0.00 | +8,609 | 29.5K | +41% | $0 |
| D | 2021-09-28 | 2021-09-24 | STRO | SUTRO BIOPHARMA, INC. | MOLINA ARTURO MD | Chief Medical Off | F - Tax | $19.23 | -2,976 | 26.5K | -10% | -$57.2K |
Purchase Sale Sale after option exercise All abbreviations